Filing Flows

Filing Flows › Omada Health (OMDA) › Q3 2026 › vs Q2 2026

Omada Health (OMDA) Q3 2026 vs Q2 2026 (quarter over quarter)

Omada Health's revenue rose $3.5M (+4%) from $87.8M in Q2 2026 to $91.3M in Q3 2026. The biggest changes: Services +$4.4M (+5%); Hardware −$943K (-13%). Gross margin 75.9% against 72.6% (+3.3 pts).

Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%, net earnings $6.6M, operating cash flow $15.1M. The chart draws each line against Q2 2026, the increases inside each band.

Omada Health: what changed, Q3 2026 vs Q2 2026Omada Health: what changed, Q3 2026 vs Q2 2026Free cash flow (OCF − capex)$11.2MOperating cash flow$11.1MWorking capital & other$9.6MGross profit$5.5MServices$4.4MGeneral & admin$4.4MOperating expenses$4.2MCost of revenue−$2.0MOperating profit$1.3MPre-tax earnings$1.3M

Margins

Q3 2026Q2 2026Change
Gross margin75.9%72.6%+3.3 pts
Operating margin5.3%4.0%+1.2 pts
Net margin7.2%6.0%+1.1 pts
Free cash flow margin16.5%4.4%+12.1 pts

Every line

LineQ3 2026Q2 2026Change%
Services$85.1M$80.7M$4.4M+5%
Hardware$6.2M$7.1M−$943K-13%
Revenue$91.3M$87.8M$3.5M+4%
Gross profit$69.3M$63.8M$5.5M+9%
Cost of revenue$22.0M$24.0M−$2.0M-8%
Other income, net$1.7M$1.7M−$14K-0.8%
Operating profit$4.8M$3.5M$1.3M+36%
Operating expenses$64.5M$60.2M$4.2M+7%
Pre-tax earnings$6.6M$5.3M$1.3M+24%
Research & development$15.3M$14.6M$646K+4%
Sales & marketing$29.1M$29.9M−$781K-3%
General & admin$20.1M$15.7M$4.4M+28%
Net earnings$6.6M$5.3M$1.3M+24%
Depreciation & amortization$1.7M$1.6M$100K+6%
Share-based compensation$5.9M$5.6M$220K+4%
Working capital & other$1.1M−$8.5M$9.6M—
Operating cash flow$15.1M$4.0M$11.1M+278%
Free cash flow (OCF − capex)$15.0M$3.9M$11.2M+289%
Capital expenditures$118K$146K−$28K-19%

Questions

How much did Omada Health's revenue grow quarter over quarter in Q3 2026?

Omada Health's revenue rose $3.5M (+4%) from $87.8M in Q2 2026 to $91.3M in Q3 2026.

What drove Omada Health's revenue change in Q3 2026?

Services +$4.4M (+5%); Hardware −$943K (-13%).

Q3 2026 results → · Compare in the interactive Sankey →